Table 3.
Vaccine up-to-date proportions in 2016 vs. 2017 by vaccine, age, county, and dose.
| Vaccine | Ages | County | |
Proportion of eligible patients vaccinated – 1st dose |
|
|
Proportion of eligible patients vaccinated – 2nd dose |
|
|---|---|---|---|---|---|---|---|---|
| September 2016 | September 2017 | p-value | September 2016 | September 2017 | p-value | |||
| Tdap | 12–13 | New Jersey | 91.9% | 89.9% | 0.021 | |||
| 12–13 | Philadelphia | 86.9% | 88.5% | 0.018 | ||||
| 12–13 | Suburbs | 91.0% | 91.7% | 0.079 | ||||
| MCV4 | 12–13 | New Jersey | 92.2% | 90.0% | 0.010 | |||
| 12–13 | Philadelphia | 86.9% | 88.7% | 0.008 | ||||
| 12–13 | Suburbs | 91.1% | 92.0% | 0.022 | ||||
| 17–18 | New Jersey | 93.6% | 95.0% | 0.053 | 62.2% | 69.0% | <.001 | |
| 17–18 | Philadelphia | 90.5% | 94.1% | <.001 | 69.8% | 74.2% | <.001 | |
| 17–18 | Suburbs | 96.1% | 97.0% | .002 | 72.1% | 79.8% | <.001 | |
| MenB | 17–18 | New Jersey | 5.9% | 31.7% | <.001 | 1.8% | 14.2% | <.001 |
| 17–18 | Philadelphia | 10.2% | 40.6% | <.001 | 1.7% | 14.2% | <.001 | |
| 17–18 | Suburbs | 18.1% | 49.8% | <.001 | 7.1% | 30.0% | <.001 | |
| HPV | 12–13 | New Jersey | 21.4% | 35.7% | <.001 | Proportion of eligible patients vaccinated – completion dose | ||
| 12–13 | Philadelphia | 71.8% | 77.9% | <.001 | ||||
| 12–13 | Suburbs | 40.3% | 51.0% | <.001 | ||||
| 17–18 | New Jersey | 59.0% | 63.8% | .001 | 47.5% | 54.8% | <.001 | |
| 17–18 | Philadelphia | 82.1% | 85.8% | <.001 | 68.8% | 73.4% | <.001 | |
| 17–18 | Suburbs | 73.7% | 76.5% | <.001 | 61.8% | 67.4% | <.001 | |